Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration

S. Foldynová-Trantírková, P. Sekyrová, K. Tmejová, E. Brumovská, O. Bernatík, W. Blankenfeldt, P. Krejcí, A. Kozubík, T. Dolezal, L. Trantírek, V. Bryja,

. 2010 ; 12 (3) : R30. [pub] 20100527

Language English Country England, Great Britain

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

INTRODUCTION: Breast cancer is one of the most common types of cancer in women. One of the genes that were found mutated in breast cancer is casein kinase 1 epsilon (CK1epsilon). Because CK1epsilon is a crucial regulator of the Wnt signaling cascades, we determined how these CK1epsilon mutations interfere with the Wnt pathway and affect the behavior of epithelial breast cancer cell lines. METHODS: We performed in silico modeling of various mutations and analyzed the kinase activity of the CK1epsilon mutants both in vitro and in vivo. Furthermore, we used reporter and small GTPase assays to identify how mutation of CK1epsilon affects different branches of the Wnt signaling pathway. Based on these results, we employed cell adhesion and cell migration assays in MCF7 cells to demonstrate a crucial role for CK1epsilon in these processes. RESULTS: In silico modeling and in vivo data showed that autophosphorylation at Thr 44, a site adjacent to the breast cancer point mutations in the N-terminal lobe of human CK1epsilon, is involved in positive regulation of the CK1epsilon activity. Our data further demonstrate that, in mammalian cells, mutated forms of CK1epsilon failed to affect the intracellular localization and phosphorylation of Dvl2; we were able to demonstrate that CK1epsilon mutants were unable to enhance Dvl-induced TCF/LEF-mediated transcription, that CK1epsilon mutants acted as loss-of-function in the Wnt/beta-catenin pathway, and that CK1epsilon mutants activated the noncanonical Wnt/Rac-1 and NFAT pathways, similar to pharmacological inhibitors of CK1. In line with these findings, inhibition of CK1 promoted cell migration as well as decreased cell adhesion and E-cadherin expression in the breast cancer-derived cell line MCF7. CONCLUSIONS: In summary, these data suggest that the mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration. In terms of molecular mechanism, our data indicate that the breast cancer point mutations in the N-terminal lobe of CK1epsilon, which are correlated with decreased phosphorylation activities of mutated forms of CK1epsilon both in vitro and in vivo, interfere with positive autophosphorylation at Thr 44.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026374
003      
CZ-PrNML
005      
20121206122801.0
007      
ta
008      
120817e20100527enk f 000 0#eng||
009      
AR
024    7_
$a 10.1186/bcr2581 $2 doi
035    __
$a (PubMed)20507565
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Foldynová-Trantírková, Silvie $u Biology Centre AS CR, v,v,i, AND University of South Bohemia, Branisovska 31, Ceske Budejovice, Czech Republic. fosil@paru.cas.cz
245    10
$a Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration / $c S. Foldynová-Trantírková, P. Sekyrová, K. Tmejová, E. Brumovská, O. Bernatík, W. Blankenfeldt, P. Krejcí, A. Kozubík, T. Dolezal, L. Trantírek, V. Bryja,
520    9_
$a INTRODUCTION: Breast cancer is one of the most common types of cancer in women. One of the genes that were found mutated in breast cancer is casein kinase 1 epsilon (CK1epsilon). Because CK1epsilon is a crucial regulator of the Wnt signaling cascades, we determined how these CK1epsilon mutations interfere with the Wnt pathway and affect the behavior of epithelial breast cancer cell lines. METHODS: We performed in silico modeling of various mutations and analyzed the kinase activity of the CK1epsilon mutants both in vitro and in vivo. Furthermore, we used reporter and small GTPase assays to identify how mutation of CK1epsilon affects different branches of the Wnt signaling pathway. Based on these results, we employed cell adhesion and cell migration assays in MCF7 cells to demonstrate a crucial role for CK1epsilon in these processes. RESULTS: In silico modeling and in vivo data showed that autophosphorylation at Thr 44, a site adjacent to the breast cancer point mutations in the N-terminal lobe of human CK1epsilon, is involved in positive regulation of the CK1epsilon activity. Our data further demonstrate that, in mammalian cells, mutated forms of CK1epsilon failed to affect the intracellular localization and phosphorylation of Dvl2; we were able to demonstrate that CK1epsilon mutants were unable to enhance Dvl-induced TCF/LEF-mediated transcription, that CK1epsilon mutants acted as loss-of-function in the Wnt/beta-catenin pathway, and that CK1epsilon mutants activated the noncanonical Wnt/Rac-1 and NFAT pathways, similar to pharmacological inhibitors of CK1. In line with these findings, inhibition of CK1 promoted cell migration as well as decreased cell adhesion and E-cadherin expression in the breast cancer-derived cell line MCF7. CONCLUSIONS: In summary, these data suggest that the mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration. In terms of molecular mechanism, our data indicate that the breast cancer point mutations in the N-terminal lobe of CK1epsilon, which are correlated with decreased phosphorylation activities of mutated forms of CK1epsilon both in vitro and in vivo, interfere with positive autophosphorylation at Thr 44.
650    _2
$a western blotting $7 D015153
650    _2
$a nádory prsu $x genetika $x metabolismus $x patologie $7 D001943
650    _2
$a duktální karcinom prsu $x genetika $x metabolismus $x patologie $7 D018270
650    _2
$a kaseinkinasa Iepsilon $x chemie $x genetika $x metabolismus $7 D048149
650    _2
$a buněčná adheze $7 D002448
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a pohyb buněk $7 D002465
650    _2
$a proliferace buněk $7 D049109
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunoprecipitace $7 D047468
650    _2
$a MAP kinasa-kinasa 4 $x metabolismus $7 D048670
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a transkripční faktory NFATC $x metabolismus $7 D050778
650    _2
$a fosforylace $7 D010766
650    _2
$a konformace proteinů $7 D011487
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a proteiny Wnt $x metabolismus $7 D051153
650    _2
$a beta-katenin $x metabolismus $7 D051176
650    _2
$a rac1 protein vázající GTP $x metabolismus $7 D020830
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sekyrová, Petra
700    1_
$a Tmejová, Katerina
700    1_
$a Brumovská, Eva
700    1_
$a Bernatík, Ondrej
700    1_
$a Blankenfeldt, Wulf
700    1_
$a Krejcí, Pavel
700    1_
$a Kozubík, Alois
700    1_
$a Dolezal, Tomás
700    1_
$a Trantírek, Lukás
700    1_
$a Bryja, Vítezslav
773    0_
$w MED00006602 $t Breast cancer research : BCR $x 1465-542X $g Roč. 12, č. 3 (20100527), s. R30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20507565 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121206122834 $b ABA008
999    __
$a ok $b bmc $g 948416 $s 783720
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 12 $c 3 $d R30 $e 20100527 $i 1465-542X $m Breast cancer research $n Breast Cancer Res $x MED00006602
LZP    __
$a Pubmed-20120817/10/04

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...